Internet Surveys and Their Impact on Adherence for Rosacea
NCT03048058
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Rosacea
Interventions
DRUG:
brimonidine topical gel 0.33% & survey
DRUG:
brimonidine topical gel 0.33% & SOC
Sponsor
Wake Forest University Health Sciences